Botulinum toxin and benign prostatic hyperplasia
Benign prostatic hyperplasia (BPH) is a clinical condition where lower urinary tract symptoms are caused by both a physically obstructing prostate as well as tight smooth muscles around the bladder outlet. Treatment of this condition with botulinum toxin has been used since 2003, but this interest h...
Saved in:
| Main Author: | Lay Guat Ng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2018-01-01
|
| Series: | Asian Journal of Urology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2214388217300905 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Choice Of treatment method for symptomatic Bladder outlet obstruction in patients with benign prostatic hyperplasia after kidney transplantation
by: S. V. Popov, et al.
Published: (2023-07-01) -
Precision medicine in the diagnosis and treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia
by: Jing-Liang Chen, et al.
Published: (2020-01-01) -
Pathophysiology of benign prostate enlargement and lower urinary tract symptoms: Current concepts
by: Cheng-Ling Lee, et al.
Published: (2017-01-01) -
Analysis of risk factors for bladder neck contracture after transurethral endoscopic surgery for benign prostatic hyperplasia
by: Yingbing Wu, et al.
Published: (2024-12-01) -
Defining minimal invasive surgical therapy for benign prostatic obstruction surgery: Perspectives from a global knowledge, attitude, and practice survey
by: Bryan Kwun-Chung Cheng, et al.
Published: (2024-01-01)